Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -13.78% is 72% above its 5-year average of -49.65%, near the high end of its 5-year range (-369.45%–57.03%).
60.24% above its 12-month average of -34.66%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.03%.
NET PROFIT MARGIN
-13.78%
NET PROFIT MARGIN AVG TTM
-34.66%
NET PROFIT MARGIN AVG 3Y
-49.06%
NET PROFIT MARGIN AVG 5Y
-49.65%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+60.24%
CURRENT VS 3Y AVG
+71.91%
CURRENT VS 5Y AVG
+72.25%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Biofrontera Inc.
Market Cap
$11.04M
Net Profit Margin
-13.78%
TTM Avg
-34.66%
3Y Avg
-49.06%
5Y Avg
-49.65%
Market Cap
$11.35M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$10.91M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
Market Cap
$10.83M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$11.47M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
Market Cap
$11.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.38M
Net Profit Margin
-2006.87%
TTM Avg
-2784.80%
3Y Avg
-10458.57%
5Y Avg
-6972.38%
Market Cap
$10.55M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.04M | -13.78% | -34.66% | -49.06% | -49.65% |
| BioVie Inc. (BIVI)vs › | $11.01M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.35M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Cerenome, Inc. (CNSY)vs › | $10.91M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.83M | N/A | -2424.09% | -1624.47% | -1082.98% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.47M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.38M | -2006.87% | -2784.80% | -10458.57% | -6972.38% |
| Lifeward Ltd. (LFWD)vs › | $10.55M | -141.28% | -101.58% | -179.50% | -204.48% |
| Caring Brands, Inc. (CABR)vs › | $10.55M | -666037.76% | -148948.78% | -148948.78% | -148948.78% |
Operating Margin
-21.9%
Net Profit Margin
-13.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5.03% |
| 2026-03-31 | -47.12% |
| 2025-12-31 | 32.98% |
| 2025-09-30 | -95.15% |
| 2025-06-30 | -58.96% |
| 2025-03-31 | -48.94% |
| 2024-12-31 | -11.12% |
| 2024-09-30 | -62.91% |
| 2024-06-30 | -3.28% |
| 2024-03-31 | -132.10% |
| 2023-12-31 | 33.28% |
| 2023-09-30 | -71.29% |
| 2023-06-30 | -168.21% |
| 2023-03-31 | -85.63% |
| 2022-12-31 | -27.45% |
| 2022-09-30 | -59.37% |
| 2022-06-30 | -19.07% |
| 2022-03-31 | 57.03% |
| 2021-12-31 | -158.21% |
| 2021-09-30 | -369.45% |
| 2021-06-30 | -62.53% |
| 2021-03-31 | -74.49% |
| 2020-12-31 | -2.17% |
| 2020-09-30 | -91.79% |
| 2020-06-30 | -154.54% |
| 2020-03-31 | -88.77% |
